A. Bordoni et al. / Tetrahedron 64 (2008) 1703e1710
1709
5). Anal. Calcd for C7H14O5: C, 47.18; H, 7.92. Found: C,
47.25; H 7.82.
3.2.12. 5-O-[3-(Trifluoromethyl)benzoyl]-b-D-gluco-
furanosidurono-6,3-lactone (16b)
A solution of 13 (2.07 g, 5.33 mmol) in AcOHeH2O (4:1,
15 mL) with H2SO4 (72 mL, 1.3 mmol) was heated under re-
flux for 1.5 h. The mixture was concentrated under diminished
pressure and the syrup obtained was crystallized from water. It
was filtered and thoroughly washed. 1H NMR spectrum of this
product showed the b-anomer with traces of the a-anomer. Re-
crystallization from CHCl3 gave pure 16b (1.15 g, 87%), mp
3.2.9. 1,2-Di-O-isopropylidene-5-O-(3-trifluoromethyl)-
benzoyl-a-D-glucofuranosidurono-6,3-lactone (13)
Compound 13 was obtained by reacting 12 (1.30 g,
6.15 mmol)26 with 3-(trifluoromethyl)benzoyl chloride
(1.10 mL, 7.20 mmol) in CH2Cl2 (15.0 mL) containing pyri-
dine (7.5 mL) at 0 ꢀC for 1 h. After the work up as used for
9, the syrup was purified by column chromatography (tolue-
neeEtOAc, 95:5) and evaporation of the fractions of Rf 0.65
(hexaneeEtOAc, 3:1) gave 13 (1.97 g, 82%), mp 102e
1
162e164 ꢀC, [a]D þ64 (c 1, acetone). H NMR (500 MHz,
DMSO-d6)
d
6.74 (d, J¼4.0 Hz, 1H, OH), 5.75 (d,
J¼6.8 Hz, 1H, H-5), 5.71 (d, J¼4.0 Hz, 1H, OH), 5.18 (d,
J¼4.0 Hz, 1H, H-1), 5.04 (dd, J¼4.8, 6.8 Hz, 1H, H-4), 4.92
(d, J¼4.8, 1H, H-3), 4.07 (d, J¼4.0 Hz, 1H, H-2). 13C NMR
(50.3 MHz, DMSO-d6) d 171.3 (C-6), 163.8 (COAr), 103.6
(C-1), 85.1 (C-3), 77.5 (C-4), 75.6 (C-2), 70.8(C-5). Anal.
Calcd for C14H11F3O7: C, 48.29; H, 3.18. Found: C, 48.34;
H, 3.26.
1
103 ꢀC, [a]D þ62 (c 1, CHCl3). H NMR (200 MHz, CDCl3)
4
d 8.42e7.15 (4H, CHAr), 6.06 (dd, J¼0.5 Hz, J¼3.7 Hz, 1H,
H-1), 5.76 (d, J¼4.4 Hz, 1H, H-5), 5.20 (ddd, 4J¼0.5 Hz,
J¼2.9, 4.4 Hz, H-4), 4.97 (d, J¼2.9 Hz, 1H, H-3), 4.89 (d,
J¼3.7 Hz, 1H, H-2), 1.52, 1.36 (2s, 6H, C(CH3)2). 13C NMR
(50.3 MHz, CDCl3) d 169.2 (C-6), 165.5 (COAr), 113.6
(C(CH3)2), 107.0 (C-1), 82.6, 82.3 (C-2, 3), 77.0 (C-4), 70.6
(C-5), 26.9, 26.5 (C(CH3)2). Anal. Calcd for C17H15F3O7: C,
52.58; H, 3.89. Found: C, 52.46; H, 4.05.
3.2.13. 5-Deoxy-a,b-D-xylo-hexofuranosidurono-6,
3-lactone (17)
Compound 17 was obtained by photolysis of 16 (0.26 g,
0.75 mmol) as described in Section 3.2. After evaporation of
the solvent, the residue was partitioned between water and
CH2Cl2. The aqueous layer was concentrated and purified by
column chromatography (EtOAcetoluene, 99:1) to afford
0.078 g (65%) of 17 (Rf 0.38, 9:1 EtOAcetoluene) as a b/a
3.2.10. 1,2-Di-O-isopropylidene-5-deoxy-a-D-
xylo-hexofuranosidurono-6,3-lactone (14)
Compound 14 was obtained by photolysis of 13 (0.29 g,
0.75 mmol) as described in Section 3.2. After evaporation of
the solvent, the syrup obtained was purified by column chro-
matography (tolueneeEtOAc, 8:1). Evaporation of fractions
with Rf 0.60 (hexaneeEtOAc, 1:1) afforded compound 14
(0.09 g, 90%), mp 89e90 ꢀC, [a]D þ73 (c 1, CHCl3), lit.28
1
mixture in 5:1 ratio. H NMR (500 MHz, D2O) data for 17b
d 5.42 (s, 1H, H-1), 5.18 (dd, J¼5.3, 7.7 Hz, 1H, H-4), 4.04
(d, J¼5.3 Hz, 1H, H-3), 4.37 (s, 1H, H-2), 3.06 (dd, J¼
7.7, 19.2 Hz, 1H, H-5), 2.75 (d, J¼19.2 Hz, 1H, H-50).
Selected signals for the a-anomer d 5.50 (d, J¼4.0 Hz, 1H,
H-1), 3.01 (dd, J¼6.5, 18.9 Hz, 1H, H-5), 2.71 (d,
J¼18.9 Hz, 1H, H-50). 13C NMR (125 MHz, D2O) for 17b
d 180.1 (C-6), 102.8 (C-1), 87.8 (C-3), 78.6, 77.2 (C-2, 4),
38.1 (C-5). For 17a d 179.7 (C-6), 97.5 (C-1), 89.2 (C-3),
75.9, 75.6 (C-2, 4), 36.1 (C-5). HRMS (ESI/APCI) calcd for
(C6H4NO5): [MþNH4]þ 178.0715, found: 178.0714.
1
mp 90e92 ꢀC. H NMR (500 MHz, CDCl3) d 5.97 (d, J¼
3.8 Hz, 1H, H-1), 5.00 (dd, J¼3.3, 4.2 Hz, 1H, H-4), 4.84
(d, J¼3.8 Hz, 1H, H-2), 4.81 (d, J¼3.3 Hz, 1H, H-3), 2.75 (d,
J¼18.0 Hz, 1H, H-5), 2.70 (dd, J¼4.2, 18.0 Hz, 1H, H-50),
1.52, 1.35 (2s, 6H, C(CH3)2). 13C NMR (125 MHz, CDCl3)
d 174.2 (C-6), 112.7 (C(CH3)2), 106.2 (C-1), 85.5 (C-3), 82.4
(C-2), 77.9 (C-4), 35.8 (C-5), 26.9, 26.5 (C(CH3)2). HRMS
(ESI/APCI) calcd for (C9H16NO5): [MþNH4]þ 218.1023,
found: 218.1025.
3.2.14. 2-Deoxy-L-xylo-hexitol (18, ‘5-deoxy-b-D-glucitol’)
Compound 17 (0.10 g) was reduced with NaBH4 (0.12 g,
3.08 mmol) and I2 (0.31 g, 1.23 mmol) in THF (5.0 mL) as de-
scribed for the preparation of 4. After the work up compound
18 (0.066 g, 63%) gave Rf 0.33 (n-PrOHeNH3eH2O,
7:0.5:0.5), [a]D þ14 (c 1, CH3OH). 1H NMR (500 MHz, D2O)
d 3.81 (m, 2H, H-2, 4), 3.70 (m, 3H, H-1, 6, 60), 3.62 (dd,
J¼6.8, 11.7 Hz, 1H, H-10), 3.49 (t, J¼4.5 Hz, 1H, H-3), 1.78
(m, 2H, H-5, 50). 13C NMR (125 MHz, D2O) d 74.1 (C-4),
72.6 (C-5), 69.3 (C-3), 63.3 (C-6), 59.1 (C-1), 35.8 (C-2).
Anal. Calcd for C6H14O5: C, 43.37; H, 8.49. Found: C,
43.18; H, 8.63.
3.2.11. 1,2-Di-O-isopropylidene-5-deoxy-
D-xylo-hexofuranose (15)
Compound 14 (0.16 g, 0.80 mmol) was reduced with the
I2eNaBH4 system,24 as described for the synthesis of 5, using
0.076 g (2.0 mmol) of NaBH4 and 0.203 g (0.8 mmol) of I2 in
THF (5.0 mL). After the work up, compound 15 (0.104 g,
64%) was obtained, [a]D ꢁ10 (c 1, water), mp 91e92 ꢀC,
lit.9 [a]D ꢁ10.5 (c 1.7, chloroform), mp 93e94.5 ꢀC. 1H NMR
(500 MHz, D2O) d 5.98 (d, J¼3.9 Hz, 1H, H-1), 4.68 (d,
J¼3.9 Hz, 1H, H-2), 4.30 (apparent dt, J¼2.6, 6.8 Hz, 1H,
H-4), 4.14 (d, J¼2.6 Hz, 1H, H-3), 3.71 (m, 2H, H-6, 60), 1.88
(q, J¼6.7 Hz, 2H, H-5, 50), 1.51, 1.35 (2s, 6H, C(CH3)2). 13C
NMR (125 MHz, D2O) d 112.9 (C(CH3)2), 104.6 (C-1), 85.2
(C-2), 78.8 (C-4), 75.1 (C-3), 59.3 (C-6), 30.6 (C-5), 26.0,
25.6 (C(CH3)2).
3.2.15. HPAECePAD analysis
Analysis by HPAECePAD was performed using a Dionex
DX 300 HPLC system with pulse amperometric detection
(PAD), set at 30 nA and E1¼þ0.05 V, E2¼þ0.60 V, and
E3¼ꢁ0.60 V. The column used was a CarboPac MA-10